Prosecution Insights
Last updated: October 04, 2026

B.R.A.H.M.S GmbH

Technology area: Biotechnology & Pharmaceuticals

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days

Analysis

B.R.A.H.M.S GmbH maintains a patent portfolio within the Biotechnology & Pharmaceuticals technology area, currently featuring 3 pending office actions. These actions are distributed across 2 distinct examiners. The presence of multiple examiners suggests that the company is managing different perspectives even within a relatively small set of active matters.

The busiest examiner identified in the data is SAOUD, CHRISTINE J. This individual handles multiple busiest examiner pending actions. Furthermore, the portfolio is spread across 2 distinct art units. This suggests that the company's intellectual property covers multiple technical niches, requiring engagement with different specialized groups within the patent office. Practitioners should note that while the portfolio spans multiple units, the workload is weighted toward a single examiner who manages most of the current matters at this time.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
1
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MISHRA, DEEPA 1 29.3% +35.2%
SAOUD, CHRISTINE J 1 58.0% +37.2%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18718852 BIOMARKERS FOR THE PREDICTION OF PRETERM BIRTH MISHRA, DEEPA —
17327271 METHODS FOR DETECTING proADM IN A CRITICALLY ILL SUBJECT WHO HAS BEEN ADMITTED TO AN INTENSIVE CARE UNIT SAOUD, CHRISTINE J —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18718852 BIOMARKERS FOR THE PREDICTION OF PRETERM BIRTH MISHRA, DEEPA —
17327271 METHODS FOR DETECTING proADM IN A CRITICALLY ILL SUBJECT WHO HAS BEEN ADMITTED TO AN INTENSIVE CARE UNIT SAOUD, CHRISTINE J —

Top Art Units

Art UnitApps
1657 1
1645 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18718852 BIOMARKERS FOR THE PREDICTION OF PRETERM BIRTH MISHRA, DEEPA 1657 §101§103§112 Non-Final OA — Pending Jun 12, 2024
17327271 METHODS FOR DETECTING proADM IN A CRITICALLY ILL SUBJECT WHO HAS BEEN ADMITTED TO AN INTENSIVE CARE UNIT SAOUD, CHRISTINE J 1645 §101§112DP Non-Final OA — Pending May 21, 2021

Managing B.R.A.H.M.S GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month